毒素A型注射到肌中及其对下骨再吸收和密度的影响. 一个系统的审查
Eduardo Luiz Wojtovicz1, Olga Martinez Alvarez2, Antonio Lopez-Davis3
1Posgraduate in Craneomandibular Dysfunction and Orofacial Pain, San Pablo CEU University, Madrid, Spain. eduardoluizw@gmail.com.
Clinical oral investigations
|August 9, 2024
概括
毒素 (BT) 注射到肌中显示没有明确的骨再吸收模式. 虽然一些研究发现了统计学意义,但对下骨密度的临床影响尚不清楚.
科学领域:
- 口腔和牙面部外科手术
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
背景情况:
- 毒素 (BT) 越来越多地用于肌,用于治疗和美学目的.
- 对下骨密度的潜在次要影响需要调查.
研究的目的:
- 系统地审查和综合有关肉毒素 (BT) 在肌中应用的二次效应的证据.
- 评估BT对下骨密度和再吸收的影响.
主要方法:
- 进行了全面的数据库搜索,截至2024年3月19日.
- 评估研究质量是使用Cochrane偏差风险工具和ROBINS-I.
- 我们使用GRADE框架来评估总体证据的可信度.
主要成果:
- 五项研究研究了BT对骨密度和肌肉再吸收的影响.
- 一般来说,在下冠状体体积/密度,下角厚度或冠状体过程体积方面没有发现显著的变化.
- 在单个和双 BT 应用组 (SMD: -0.99) 之间注意到下角体积的统计学上显著差异.
结论:
- 证据不确定毒素的应用和骨再吸收之间存在明显的关联.
- 虽然一些发现具有统计学意义,但骨密度变化的临床相关性和大小需要进一步澄清.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
664
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
664
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
402
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
402
Skeletal Muscle Relaxants: Adverse Effects
349
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
349


